logo

Valiant Laboratories Ltd. Financials

15:55 Jul 25

Valiant Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
94.24
-3.97 (-4.04%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Valiant Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
94.24
-3.97 (-4.04%)
15:55 Jul 25
Quality
image/svg+xml

27/100
Low Financial Strength

Valuation
image/svg+xml

18/100
Expensive Valuation

Technical

43/100
Technically Neutral

Strength

3

Weakness

11

Opportunity

1

Threats

0

-0.93 %

ROE %

-0.54 %

ROA %

-0.41

EPS

53.93

BVPS

-1.65 %

Net Profit Margin

Mar 2023 Mar 2024 Mar 2025
Net Sales
333.91 182.06 133.38
Operating Expenses +
298.83 190.46 138.06
Raw Material
277.56 169.39 112.74
Increase Decrease in Cost
-0.24 -1.14 3.86
Other Manufacturing Expense
0 0 0
Employee Cost
4.61 4.31 4.39
Miscellaneous Expenses
17.46 17.9 18.19
Operating Profit
35.08 -8.4 -4.68
Other Income
4.86 9.68 5.43
Depreciation
1.56 1.97 2.09
Interest
0.25 0.08 0.18
Profit before tax and exceptio..
38.14 -0.77 -1.51
Exceptional Items
0 0 0
PBT
38.14 -0.77 -1.51
Provision for Taxation
9.14 -1.09 0.69
Net Profit
29 0.32 -2.2
NET Profit after MI
29 0.32 -2.2
EPS
8.91 0.13 -0.51
Operating Profit Margin (%)
10.51 -4.61 -3.51
Net Profit Margin (%)
8.69 0.18 -1.65

Valiant Laboratories Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Jun 25 Mar 25 Dec 24 Sep 24 Jun 24
Promoter 74.90 74.90 74.90 74.90 74.90
FII 0.60 0.60 0.00 0.00 1.90
MF 0.00 0.00 0.00 0.00 0.00
Others 0.50 0.00 0.00 0.00 0.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: